PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Drospirenone 514 Drug Disease Vertigo 10,084 1 0.00 -1.00 0.00 0.57
Drospirenone 514 Drug Disease Infertility 35,448 1 0.00 -1.00 0.00 0.54
Sepsis 64,798 Disease Disease Tinea Pedis 938 1 0.00 -1.00 0.00 0.51
Sepsis 64,798 Disease Disease Heel Pain 634 1 0.00 -1.00 0.00 0.52
Sepsis 64,798 Disease Disease Memory Loss 2,577 1 0.00 -1.00 0.00 0.49
Sepsis 64,798 Disease Disease Meningitis Bacterial 14 1 0.00 -0.96 0.07 0.59
Sepsis 64,798 Disease Disease Dysfunctional Uterine Bleeding 778 1 0.00 -1.00 0.00 0.51
Sepsis 64,798 Disease Disease Orthopedic Disorders 168 1 0.00 -1.00 0.01 0.55
Sepsis 64,798 Disease Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.59
Sepsis 64,798 Disease Disease Schizoaffective Disorder 3,104 1 0.00 -1.00 0.00 0.48
CLK1 62 Target Disease Breast Cancer 173,695 1 0.00 -0.99 0.02 0.54
CLK1 62 Target Disease Asthma 109,610 1 0.00 -0.99 0.02 0.55
CLK1 62 Target Disease Down Syndrome 10,290 1 0.00 -0.99 0.02 0.61
CLK1 62 Target Disease Inflammation 252,734 1 0.00 -0.99 0.02 0.53
CLK1 62 Target Disease Glioblastoma 17,933 1 0.00 -0.99 0.02 0.59
BTK 1,263 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.00 0.50
BTK 1,263 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.55
BTK 1,263 Target Disease Urticaria 10,717 1 0.00 -1.00 0.00 0.55
Doxycycline Hyclate 145 Drug Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
Doxycycline Hyclate 145 Drug Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
Doxycycline Hyclate 145 Drug Disease Vertigo 10,084 1 0.00 -1.00 0.01 0.59
Doxycycline Hyclate 145 Drug Disease Urticaria 10,717 1 0.00 -1.00 0.01 0.59
Carbonic Anhydrase III 272 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.62
Carbonic Anhydrase III 272 Target Disease Psoriasis 26,882 1 0.00 -1.00 0.00 0.56
Carbonic Anhydrase III 272 Target Disease Pain 409,851 1 0.00 -1.00 0.00 0.50
Carbonic Anhydrase III 272 Target Disease Malnutrition 27,452 1 0.00 -1.00 0.00 0.56
Carbonic Anhydrase III 272 Target Disease Glioblastoma 17,933 1 0.00 -1.00 0.00 0.57
Multidrug Resistance-Associated Protein 2 462 Target Disease Asthma 109,610 1 0.00 -1.00 0.00 0.51
Multidrug Resistance-Associated Protein 2 462 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.54
Multidrug Resistance-Associated Protein 2 462 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.00 0.52
Multidrug Resistance-Associated Protein 2 462 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -1.00 0.00 0.59
Multidrug Resistance-Associated Protein 2 462 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.51
Multidrug Resistance-Associated Protein 2 462 Target Disease Urticaria 10,717 1 0.00 -1.00 0.00 0.57
Retinoic Acid Receptor Alpha 1,068 Target Disease Asthma 109,610 1 0.00 -1.00 0.00 0.50
Retinoic Acid Receptor Alpha 1,068 Target Disease Nephrotic Syndrome 14,681 1 0.00 -1.00 0.00 0.54
Retinoic Acid Receptor Alpha 1,068 Target Disease Ulcers 45,142 1 0.00 -1.00 0.00 0.52
Retinoic Acid Receptor Alpha 1,068 Target Disease Contraception 21,402 1 0.00 -1.00 0.00 0.53
APOC1 126 Target Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
APOC1 126 Target Disease Leukemia 162,805 1 0.00 -1.00 0.01 0.53
APOC1 126 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
APOC1 126 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.01 0.57
Adenosine (Adenocard I.V.)- FDA 1 Drug Disease Pain 409,851 1 0.00 -0.71 1.00 0.59
Adenosine (Adenocard I.V.)- FDA 1 Drug Disease Ulcers 45,142 1 0.00 -0.71 1.00 0.63
Diabetic Retinopathy 14,494 Disease Disease Tinea Pedis 938 1 0.00 -1.00 0.00 0.55
Diabetic Retinopathy 14,494 Disease Disease Autism 20,962 1 0.00 -1.00 0.00 0.47
Diabetic Retinopathy 14,494 Disease Disease Hemorrhoids 2,290 1 0.00 -1.00 0.00 0.53
Diabetic Retinopathy 14,494 Disease Disease Sleep Disorders 6,847 1 0.00 -1.00 0.00 0.50
Diabetic Retinopathy 14,494 Disease Disease Iron Deficiency Anemia 5,021 1 0.00 -1.00 0.00 0.51
Diabetic Retinopathy 14,494 Disease Disease Muscle Weakness 9,178 1 0.00 -1.00 0.00 0.49
Diabetic Retinopathy 14,494 Disease Disease Angioedema 3,997 1 0.00 -1.00 0.00 0.51